Sandra C. Raymond, President and CEO of the Lupus Foundation of America joined U.S. Representative Robin Kelly (D-IL), of…
Articles by Charles Moore
The American College of Rheumatology’s (ACR) The Lupus Initiative (TLI) has awarded a one-year, $500,000 grant from the…
Janus Biotherapeutics (Janus), a Boston, Massachusetts based autoimmunity therapeutics company dedicated to development of novel, orally available compounds for…
Sandra C. Raymond, President and CEO of the Lupus Foundation of America recently participated in a briefing for U.S.
The Senate Appropriations Committee’s 2016 spending bill passed June 25 includes some good news for people with lupus. Sandra C.
Raanana, Israel based XTL Biopharmaceuticals Ltd. (XTL) has announced that following evaluation of market opportunity for its pipeline products its…
Paris, France based Neovacs, a biotech firm specializing in active immunotherapies for treating autoimmune diseases, has announced establishment of a…
The New York and Chicago based non-profit Lupus Research Institute (LRI) Coalition, along with lupus patients nationwide are hopeful…
According to research recently published in the American Society for Microbiology’s journal Applied and Environmental Microbiology, Lactobacillus — a probiotic…